ISSN: 0165-5728

Journal Home

Journal Guideline

Journal of Neuroimmunology Q2 Unclaimed

Elsevier B.V. Netherlands

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Neuroimmunology is a journal indexed in SJR in Immunology and Immunology and Allergy with an H index of 155. It has an SJR impact factor of 0,897 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,897.

Journal of Neuroimmunology focuses its scope in these topics and keywords: multiple, sclerosis, model, icam, antibodies, chronic, brain, polymorphism, progressive, protein, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Immunology (Q2) Immunology and Allergy (Q2) Immunology and Allergy (Q2) Neurology (Q2) Neurology (clinical) (Q2) Neurology (clinical) (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,897

SJR Impact factor

155

H Index

156

Total Docs (Last Year)

629

Total Docs (3 years)

7111

Total Refs

1872

Total Cites (3 years)

608

Citable Docs (3 years)

2.95

Cites/Doc (2 years)

45.58

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical and Experimental Allergy Q2
Expert Review of Clinical Immunology Q2
Immunology and Cell Biology Q2
International Reviews of Immunology Q2
Clinical and Experimental Immunology Q2

Compare this journals

Aims and Scope

Best articles by citations

Pituitary adenylate cyclase-activating polypeptides ( PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP

Cytokines and immunity in multiple sclerosis: the dual signal hypothesis

MRI involvement in relapsing remitting MS: Correlation with functional systems and EDSS

Increased deposition of extracellular matrix components in the thymus gland of MDX mouse: correlation with the muscular lesion

Polymorphisms of the promoter region of the tumor necrosis factor a gene and the outcome of MS

Acute unilateral papillitis versus retrobulbar neuritis: Relation to multiple sclerosis

Rejection of xenogeneic glial cells grafted into spinal cord white matter results in bystander demyelination

Clinical and laboratory evaluation op serum complement and of circulating immune complexes in patients with multiple sclerosis

Static urethral pressure profile (S.U.P.P.) or video-dynamic pressure profile (V.D.P.P.) in the evaluation of multiple sclerosis (M.S.)?

Intravenous immunoglobulin (IVIG) for the treatment of progressive multiple sclerosis (MS)

The immune response to a subdominant epitope in myelin basic protein exon-2 results in immunity to intra-and intermolecular dominant epitopes

Antibody dependent cell-mediated cytotoxicity - an additional mechanism in human autoimmune myasthenia gravis

SHOW MORE ARTICLES

Use of human prolactin as a therapeutic protein to potentiate immunohematopoietic function

Multiple sclerosis associated with familial Mediterranean fever

Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis

Interleukin-4 deficiency facilitates development of experimental myasthenia gravis and precludes its prevention by nasal administration of CD4+ epitope sequences of the acetylcholine receptor

Prolactin in autoimmunity and antitumor defence

Preface

Lytic effector cell activity and major depressive disorder in patients with breast cancer: a prospective study

CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis

Affective and schizophrenic syndromes as primary symptoms in multiple sclerosis (MS)?

Induction of myelination in the central nervous system by axonal electrical activity

The effects of recombinant interleukin-1 receptor antagonist (rlL-1ra) on the adoptive transfer of experimental autoimmune encephalomyelitis (EAE) in rats

TGF-beta1-mediated inhibition of glial cell proliferation and down-regulation of ICAM-1 IS interrupted by IFN- gamma